The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
Open Access
- 29 November 1990
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 323 (22), 1505-1511
- https://doi.org/10.1056/nejm199011293232201
Abstract
Nonrheumatic atrial fibrillation increases the risk of stroke, presumably from atrial thromboemboli. There is uncertainty about the efficacy and risks of long-term warfarin therapy to prevent stroke.Keywords
This publication has 12 references indexed in Scilit:
- Preliminary Report of the Stroke Prevention in Atrial Fibrillation StudyThe New England Journal of Medicine, 1990
- Antithrombotic Therapy in Atrial FibrillationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1989
- PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATIONThe Lancet, 1989
- Stopping rules and estimation problems in clinical trialsStatistics in Medicine, 1988
- Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham StudyArchives of Internal Medicine, 1987
- Meta-Analyses of Randomized Controlled TrialsThe New England Journal of Medicine, 1987
- Epidemiologic assessment of chronic atrial fibrillation and risk of strokeNeurology, 1978
- Influence of etiology of atrial fibrillation on incidence of systemic embolismThe American Journal of Cardiology, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976